Skip to main content
. 2021 Jun 9;16(4):357–366. doi: 10.1007/s11899-021-00626-4

Table 1.

Systemic amyloidosis subtypes

Amyloid type Acquired or hereditary Precursor protein Underlying disorder Heart Kidney liver Liver PN/AN ST
AL Acquired Monoclonal immunoglobulin light chain Plasma cell dyscrasia +++ +++ ++ + ++
hATTR Hereditary Abnormal TTR Mutated TTR gene +++ - - +++ -
wtATTR Acquired Normal TTR - +++ - - - +
AA Acquired SAA Inflammatory disorders + late +++ + late + -
ALECT2 Acquired LECT2 Uncertain - +++ ++ - -
AGel Hereditary Abnormal gelsolin Mutation in gelsolin gene - + - ++ cranial -
AB2M Acquired or hereditary AB2M Long term dialysis - - - + +
AApoA1 Hereditary Abnormal ApoA1 Mutations in apolipoprotein A1 Gene + ++ ++ + + testis

AL, light chain amyloidosis; hATTR, hereditary transthyretin amyloidosis; wtATTR, wild-type transthyretin amyloidosis; AA, secondary amyloidosis; ALECT2: leukocyte chemotactic factor 2 amyloidosis; AB2M, beta-2-microglobulin amyloidosis; AApoA1, apolipoprotein A1 amyloidosis; PN, peripheral neuropathy; AN, autonomic neuropathy; ST, soft tissue; +++, very common; ++, common; +, less common; -, not reported